<![CDATA[Biotek-snakken — September 2023]]>Godmorgen...

]]>https://dev.proinvestor.com/forum/topic/401435/biotek-snakken-september-2023RSS for NodeSat, 06 Jun 2026 04:41:01 GMTFri, 01 Sep 2023 02:09:50 GMT60<![CDATA[Reply to Biotek-snakken — September 2023 on Fri, 29 Sep 2023 03:58:03 GMT]]>Godmorgen 🙂

]]>https://dev.proinvestor.com/forum/post/8066350https://dev.proinvestor.com/forum/post/8066350Fri, 29 Sep 2023 03:58:03 GMT<![CDATA[Reply to Biotek-snakken — September 2023 on Fri, 29 Sep 2023 01:19:10 GMT]]>Godmorgen...

]]>https://dev.proinvestor.com/forum/post/8066353https://dev.proinvestor.com/forum/post/8066353Fri, 29 Sep 2023 01:19:10 GMT<![CDATA[Reply to Biotek-snakken — September 2023 on Thu, 28 Sep 2023 03:21:46 GMT]]>Morning 🙂

]]>https://dev.proinvestor.com/forum/post/8066351https://dev.proinvestor.com/forum/post/8066351Thu, 28 Sep 2023 03:21:46 GMT<![CDATA[Reply to Biotek-snakken — September 2023 on Thu, 28 Sep 2023 01:47:35 GMT]]>Godmorgen...

]]>https://dev.proinvestor.com/forum/post/8066348https://dev.proinvestor.com/forum/post/8066348Thu, 28 Sep 2023 01:47:35 GMT<![CDATA[Reply to Biotek-snakken — September 2023 on Wed, 27 Sep 2023 11:23:34 GMT]]>STENOCARE - Significant growth in market share and patients in Denmark https://www.proinvestor.com/boards/115763

]]>https://dev.proinvestor.com/forum/post/8066345https://dev.proinvestor.com/forum/post/8066345Wed, 27 Sep 2023 11:23:34 GMT<![CDATA[Reply to Biotek-snakken — September 2023 on Mon, 25 Sep 2023 18:56:34 GMT]]>Biosergen partnerskabsaftale med den indiske gigant Alkem Laboratories

Fik opmærksomhed i flere globale medier

Link Preview Image
Alkem Laboratories, Biosergen AB ink pact for invasive fungal diseases treatment - CNBC TV18

Business News: Get the latest Business News, Live Share & Stock Market Updates, Top News from India and across world. Read Top Business News and updates on financial, economic and banking news on CNBCTV18.

favicon

CNBCTV18 (www.cnbctv18.com)

Det svensk-danske selskab foretog en børsnotering på 231 mSEK pre-money, men er nu vurderet til knap 70 mSEK trods positive resultater og nu en aftale med big pharma.

]]>https://dev.proinvestor.com/forum/post/8066346https://dev.proinvestor.com/forum/post/8066346Mon, 25 Sep 2023 18:56:34 GMT<![CDATA[Reply to Biotek-snakken — September 2023 on Sun, 24 Sep 2023 02:12:07 GMT]]>Godmorgen...

]]>https://dev.proinvestor.com/forum/post/8066349https://dev.proinvestor.com/forum/post/8066349Sun, 24 Sep 2023 02:12:07 GMT<![CDATA[Reply to Biotek-snakken — September 2023 on Sat, 23 Sep 2023 11:17:08 GMT]]>Sukkeralf jeg hænger stadig ved lever i håbet 🙂

]]>https://dev.proinvestor.com/forum/post/8066344https://dev.proinvestor.com/forum/post/8066344Sat, 23 Sep 2023 11:17:08 GMT<![CDATA[Reply to Biotek-snakken — September 2023 on Fri, 22 Sep 2023 18:37:44 GMT]]>https://www.streetinsider.com/Corporate+News/Zymeworks+(ZYME)+and+BeiGene+(BGNE)+Terminate+zanidatamab+zovodotin+Deal%2C/22187512.html

]]>https://dev.proinvestor.com/forum/post/8066341https://dev.proinvestor.com/forum/post/8066341Fri, 22 Sep 2023 18:37:44 GMT<![CDATA[Reply to Biotek-snakken — September 2023 on Fri, 22 Sep 2023 18:37:37 GMT]]>Og at en nyhed som dette ikke ligefrem er nem at finde på deres hjemmeside, synes jeg også er skidt - men de anser måske heller selv, at ZW49 har nogen værdi.

]]>https://dev.proinvestor.com/forum/post/8066342https://dev.proinvestor.com/forum/post/8066342Fri, 22 Sep 2023 18:37:37 GMT<![CDATA[Reply to Biotek-snakken — September 2023 on Fri, 22 Sep 2023 18:29:38 GMT]]>Andre der stadig hænger på i Zymeworks? Min dårligste investering ever og føler at begge CEO´er (Ali Tehrani og Kenneth Galbraith) i den grad misleder investorerne med deres konstante totalt positive indstilling til hvordan det går.

]]>https://dev.proinvestor.com/forum/post/8066340https://dev.proinvestor.com/forum/post/8066340Fri, 22 Sep 2023 18:29:38 GMT<![CDATA[Reply to Biotek-snakken — September 2023 on Fri, 22 Sep 2023 10:45:01 GMT]]>Amerikansk biotekselskab stiger efter positive forsøg med patienter med blærekræft https://www.proinvestor.com/investornyt/1053283/amerikansk-biotekselskab-stiger-efter-positive-forsog-med-patienter-med-blaerekraeft

]]>https://dev.proinvestor.com/forum/post/8066354https://dev.proinvestor.com/forum/post/8066354Fri, 22 Sep 2023 10:45:01 GMT<![CDATA[Reply to Biotek-snakken — September 2023 on Fri, 22 Sep 2023 06:41:49 GMT]]>Der er fyldt rigtigt godt op på Biotek-kirkegården, så mit skriv er ingen anbefaling og tjener blot som inspiration 🙂

]]>https://dev.proinvestor.com/forum/post/8066343https://dev.proinvestor.com/forum/post/8066343Fri, 22 Sep 2023 06:41:49 GMT<![CDATA[Reply to Biotek-snakken — September 2023 on Fri, 22 Sep 2023 06:37:51 GMT]]>Redeye har for Calliditas Therapeutics et fair value base kursmål på: kurs 295

https://www.redeye.se/company/calliditas-therapeutics

Calliditas Therapeutics Short: 6,02%

https://allaaktier.se/calliditas-therapeutics/blankning

]]>https://dev.proinvestor.com/forum/post/8066338https://dev.proinvestor.com/forum/post/8066338Fri, 22 Sep 2023 06:37:51 GMT<![CDATA[Reply to Biotek-snakken — September 2023 on Fri, 22 Sep 2023 05:11:05 GMT]]>https://www.calliditas.se/en/wp-content/uploads/sites/2/2021/10/Presentation-Interim-Report-Q2-2023.pdf

]]>https://dev.proinvestor.com/forum/post/8066347https://dev.proinvestor.com/forum/post/8066347Fri, 22 Sep 2023 05:11:05 GMT<![CDATA[Reply to Biotek-snakken — September 2023 on Fri, 22 Sep 2023 05:10:20 GMT]]>Calliditas Therapeutics

Link til deres hjemmeside:

https://www.calliditas.se/en/

Q2 2023 REPORT:

https://www.calliditas.se/en/wp-content/uploads/sites/2/2021/10/Presentation-Interim-Report-Q2-2023.pdf

]]>https://dev.proinvestor.com/forum/post/8066337https://dev.proinvestor.com/forum/post/8066337Fri, 22 Sep 2023 05:10:20 GMT<![CDATA[Reply to Biotek-snakken — September 2023 on Fri, 22 Sep 2023 04:59:19 GMT]]>Jeg har haft Calliditas Therapeutics i kikkerten i lang tid, men den kom aldrig ned under kurs 90 som var mit target. Så kom den på listen hos DI og steg den en del og faldt lidt tilbage. I går løb den endeligt helt væk pga. dårligt nyt fra en konkurrent (Traveres). Den streg voldsomt men faldt en del tilbage og jeg nåede at få en lille position lige før luk i omkring kurs 103.

]]>https://dev.proinvestor.com/forum/post/8066334https://dev.proinvestor.com/forum/post/8066334Fri, 22 Sep 2023 04:59:19 GMT<![CDATA[Reply to Biotek-snakken — September 2023 on Fri, 22 Sep 2023 04:51:29 GMT]]>God morgen 🙂

]]>https://dev.proinvestor.com/forum/post/8066339https://dev.proinvestor.com/forum/post/8066339Fri, 22 Sep 2023 04:51:29 GMT<![CDATA[Reply to Biotek-snakken — September 2023 on Fri, 22 Sep 2023 01:24:16 GMT]]>Godmorgen...

]]>https://dev.proinvestor.com/forum/post/8066335https://dev.proinvestor.com/forum/post/8066335Fri, 22 Sep 2023 01:24:16 GMT<![CDATA[Reply to Biotek-snakken — September 2023 on Thu, 21 Sep 2023 04:14:59 GMT]]>God morgen 🙂

]]>https://dev.proinvestor.com/forum/post/8066332https://dev.proinvestor.com/forum/post/8066332Thu, 21 Sep 2023 04:14:59 GMT<![CDATA[Reply to Biotek-snakken — September 2023 on Thu, 21 Sep 2023 02:11:21 GMT]]>Godmorgen...

]]>https://dev.proinvestor.com/forum/post/8066336https://dev.proinvestor.com/forum/post/8066336Thu, 21 Sep 2023 02:11:21 GMT<![CDATA[Reply to Biotek-snakken — September 2023 on Wed, 20 Sep 2023 04:49:31 GMT]]>God morgen 🙂

]]>https://dev.proinvestor.com/forum/post/8066352https://dev.proinvestor.com/forum/post/8066352Wed, 20 Sep 2023 04:49:31 GMT<![CDATA[Reply to Biotek-snakken — September 2023 on Wed, 20 Sep 2023 01:51:47 GMT]]>Godmorgen...

]]>https://dev.proinvestor.com/forum/post/8066329https://dev.proinvestor.com/forum/post/8066329Wed, 20 Sep 2023 01:51:47 GMT<![CDATA[Reply to Biotek-snakken — September 2023 on Tue, 19 Sep 2023 10:50:07 GMT]]>https://biovica.com/mfn_news/biovica-signs-us-agreement-with-leading-healthcare-provider-in-arizona/

]]>https://dev.proinvestor.com/forum/post/8066330https://dev.proinvestor.com/forum/post/8066330Tue, 19 Sep 2023 10:50:07 GMT